134 related articles for article (PubMed ID: 14563448)
1. Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus.
Labudovic DD; Toseska KN; Alabakovska SB; B Todorova B
Clin Biochem; 2003 Oct; 36(7):545-51. PubMed ID: 14563448
[TBL] [Abstract][Full Text] [Related]
2. Frequency distribution of apoprotein(a) isoforms in patients with diabetes mellitus and healthy subjects.
Labudović DD; Toseska KN; Alabakovska SB; Dimitrovski C; Jurhar M; Isjanovska R; Spiroski M; Todorova BB
Croat Med J; 2003 Aug; 44(4):435-40. PubMed ID: 12950147
[TBL] [Abstract][Full Text] [Related]
3. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.
Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K
Diabetologia; 1995 Dec; 38(12):1434-42. PubMed ID: 8786017
[TBL] [Abstract][Full Text] [Related]
4. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
Wollesen F; Dahlén G; Berglund L; Berne C
Diabetes Care; 1999 Jan; 22(1):93-8. PubMed ID: 10333909
[TBL] [Abstract][Full Text] [Related]
5. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).
Saku K; Zhang B; Liu R; Shirai K; Arakawa K
Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.
Kollerits B; Drechsler C; Krane V; Lamina C; März W; Dieplinger H; Ritz E; Wanner C; Kronenberg F;
Nephrol Dial Transplant; 2016 Nov; 31(11):1901-1908. PubMed ID: 26754832
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.
Jürgens G; Taddei-Peters WC; Költringer P; Petek W; Chen Q; Greilberger J; Macomber PF; Butman BT; Stead AG; Ransom JH
Stroke; 1995 Oct; 26(10):1841-8. PubMed ID: 7570736
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
Milionis HJ; Efstathiadou Z; Tselepis AD; Bairaktari ET; Tsironis LD; Tsatsoulis A; Elisaf MS
Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105
[TBL] [Abstract][Full Text] [Related]
9. Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size.
Rainwater DL; MacCluer JW; Stern MP; VandeBerg JL; Haffner SM
Diabetes; 1994 Jul; 43(7):942-6. PubMed ID: 8013760
[TBL] [Abstract][Full Text] [Related]
10. Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus.
Klausen IC; Schmidt EB; Lervang HH; Gerdes LU; Ditzel J; Faergeman O
Eur J Clin Invest; 1992 Aug; 22(8):538-41. PubMed ID: 1425859
[TBL] [Abstract][Full Text] [Related]
11. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
Briones ER; Mao SJ; Palumbo PJ; O'Fallon WM; Chenoweth W; Kottke BA
Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
[TBL] [Abstract][Full Text] [Related]
12. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.
Hernández C; Chacón P; García-Pascual L; Simó R
Diabetes Care; 2001 Feb; 24(2):350-5. PubMed ID: 11213891
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus.
Hirata K; Kikuchi S; Saku K; Jimi S; Zhang B; Naito S; Hamaguchi H; Arakawa K
Kidney Int; 1993 Nov; 44(5):1062-70. PubMed ID: 8264136
[TBL] [Abstract][Full Text] [Related]
14. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.
Kronenberg F; Kronenberg MF; Kiechl S; Trenkwalder E; Santer P; Oberhollenzer F; Egger G; Utermann G; Willeit J
Circulation; 1999 Sep; 100(11):1154-60. PubMed ID: 10484534
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
[TBL] [Abstract][Full Text] [Related]
16. Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians.
Gambhir JK; Kaur H; Prabhu KM; Morrisett JD; Gambhir DS
Clin Biochem; 2008 May; 41(7-8):453-8. PubMed ID: 18280807
[TBL] [Abstract][Full Text] [Related]
17. Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes.
Ruiz J; Thillet J; Huby T; James RW; Erlich D; Flandre P; Froguel P; Chapman J; Passa P
Diabetologia; 1994 Jun; 37(6):585-91. PubMed ID: 7926343
[TBL] [Abstract][Full Text] [Related]
18. Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients.
Ribault A; Durou MR; Letellier C; Wojcik F; Poirier JY; Ruelland A
Diabetes Metab; 2000 Apr; 26(2):107-12. PubMed ID: 10804324
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors.
Ishikawa S; Deguchi T; Hara K; Takuma S; Kayaba K; Tsutsumi A; Kario K; Igarashi M
J Epidemiol; 1999 Feb; 9(1):32-9. PubMed ID: 10098351
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications.
Gazzaruso C; Garzaniti A; Buscaglia P; D'Annunzio G; Porta A; Vandelli G; Lorini R; Finardi G; Fratino P; Geroldi D
Acta Diabetol; 1998 Apr; 35(1):13-8. PubMed ID: 9625284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
